Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
PTHS — Pelthos Therapeutics Inc.
AMEX
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 13, 2026
REVENUE
$15.6M +43.1%
NET MARGIN
-150.1% -56.2 PTS
EPS
-$6.62 -114.2%
FREE CASH FLOW
-$7.7M +42.4%

No summary has been written for this call yet.